C630004H02Rik Activators
C630004H02Rik Activators are a group of chemical compounds that facilitate the enhancement of C630004H02Rik through targeted effects on specific cellular signaling pathways. Forskolin and 8-Bromo-cAMP act through the elevation of intracellular cAMP levels and subsequent activation of PKA, which can lead to the phosphorylation of proteins that interact with or affect C630004H02Rik, promoting its activity. Additionally, Phorbol 12-myristate 13-acetate (PMA) and 4-Phorbol 12,13-didecanoate (4-PDD) activate PKC and TRPV4 channels respectively, initiating signaling cascades that culminate in the functional enhancement of C630004H02Rik. The polyphenol Epigallocatechin gallate (EGCG) and the kinase inhibitor H-89 apply selective pressure on various kinase pathways, potentially shifting the balance in favor of those that upregulate C630004H02Rik activity. Furthermore, Ionomycin and Insulin, by modulating calcium and PI3K/Akt signaling pathways, can influence the cellular mechanisms in which C630004H02Rik is involved, thus indirectly enhancing its functional role.
The activity of C630004H02Rik is further influenced by compounds that modulate the state of phosphorylation within the cell. Okadaic acid, by inhibiting protein phosphatases such as PP1 and PP2A, prevents the dephosphorylation of proteins within the signaling networks that involve C630004H02Rik, thereby maintaining its active conformation. Anisomycin activates stress-activated protein kinases, which can lead to protein modifications that enhance the activity of C630004H02Rik. Bisindolylmaleimide I, as an inhibitor of PKC, may alter signaling cascades and potentially enhance compensatory pathways that increase the activity of C630004H02Rik. Lastly, Dibutyryl cAMP (db-cAMP) serves as a stable analog of cAMP, further engaging PKA and promoting phosphorylation events that positively affect the activity of C630004H02Rik. Collectively, these activators, by means of their targeted effects on cellular signaling, facilitate the enhancement of C630004H02Rik-mediated functions without the need for upregulating its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that mimics diacylglycerol (DAG). PKC activation can lead to the phosphorylation and functional modulation of proteins that are part of the signaling cascade in which C630004H02Rik participates, thereby enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways that influence the functional state of C630004H02Rik. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Through PKA activation, it can modulate the signaling pathways that control the activity of C630004H02Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that inhibits certain protein kinases. This inhibition can result in the activation of alternative signaling pathways that subsequently enhance the functional activity of C630004H02Rik. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which is involved in a variety of cellular processes. Activation of this pathway can lead to the phosphorylation of downstream targets that may interact with or modulate the activity of C630004H02Rik. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases can prevent dephosphorylation of proteins within the signaling networks that include C630004H02Rik, thereby sustaining its active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of stress-activated protein kinases such as JNK and p38 MAPK. Activation of these pathways can result in the modification of proteins that are functionally connected to C630004H02Rik, enhancing its activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of PKC. By inhibiting PKC, it can alter signaling cascades and potentially enhance compensatory pathways that increase the activity of C630004H02Rik. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is an inhibitor of PKA. By inhibiting PKA, it may induce changes in signaling networks that compensate by activating pathways which enhance the activity of C630004H02Rik. | ||||||